Covered recipient · General Payments record
SANDHYA GUMASTE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$303.61
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.42 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $45.71 | 3 |
| Lilly USA, LLC | $39.40 | 2 |
| GlaxoSmithKline, LLC. | $30.75 | 2 |
| Neurocrine BioSciences, Inc. | $23.86 | 1 |
| Amgen Inc. | $19.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.70 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115685889 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.96 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104545212 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.31 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104764248 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.44 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104697420 | CMS |
| GlaxoSmithKline, LLC. | $15.77 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116464320 | CMS |
| GlaxoSmithKline, LLC. | $14.98 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116726606 | CMS |
| Lilly USA, LLC | $15.89 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135388361 | CMS |
| Lilly USA, LLC | $23.51 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135414813 | CMS |
| Neurocrine Biosciences, Inc. | $23.86 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150843572 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.